NCT02151760View on ClinicalTrials.gov

Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

April 30, 2020

Study Completion Date

April 30, 2020

Conditions
Metastatic Prostate Cancer
Interventions
DRUG

18F-DCFPyL

Trial Locations (1)

21287

Johns Hopkins University, Baltimore

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT02151760 - Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter